|
2007
|
Invention
|
Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom an... |
|
|
Invention
|
Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in ... |
|
2006
|
Invention
|
Identification of novel protein targets on the surface of stressed cells.
The present invention ... |
|
|
Invention
|
Identification of novel protein targets on the surface of stressed cells. The present invention i... |
|
|
Invention
|
Crystal structure of human urokinase plasminogen activator amino teminal fragment bound to its re... |
|
|
Invention
|
Crystal structure of human urokinase plasminogen activator amino terminal fragment bound to its r... |
|
|
Invention
|
Methods and compositions for increasing bioavailability of thiomolybdate and thiotungstate compou... |
|
|
Invention
|
Treatment of inflammatory bowel disease (ibd) with anti-angiogenic compounds. Inhibitors of angio... |
|
|
Invention
|
Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent. Human kininogen... |
|
|
Invention
|
Pyrimidine-fused diazepine derivatives and indole-fused pteridines. The present invention relates... |
|
|
Invention
|
Compositions containing the anti-angiogenic phscn-peptide. Described herein are compositions/form... |
|
|
Invention
|
Acid addition salts of ac-phscn-nh2. Acid addition salts of Ac-PHSCN-NH2, methods of making acid ... |
|
2005
|
Invention
|
Formulations of thiomolybdate or thiotungstate compounds and uses thereof.
Formulations of thiom... |
|
|
Invention
|
Ligands binding the complex of urokinase-type plasminogen activator (upa) and its receptor (upar)... |
|
|
Invention
|
Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic a... |
|
|
Invention
|
Formulations of thiomolybdate or thiotungstate compounds and uses thereof. Formulations of thiomo... |
|
2004
|
Invention
|
Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, comp... |
|
|
Invention
|
Thiotungstate analogues and uses thereof. The current invention provides novel thiotungstate deri... |
|
2003
|
Invention
|
Peptides which target tumor and endothelial cells, compositions and uses thereof.
The present in... |
|
|
Invention
|
Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compos... |
|
|
Invention
|
Peptides which target tumor and endothelial cells, compositions and uses thereof. The present inv... |
|
|
Invention
|
Thiomolybdate analogues and uses thereof. The current invention provides novel thiomolybdate deri... |
|
|
Invention
|
Cell surface tropomyosin as a target of angiogenesis inhibition. The present invention is directe... |
|
2002
|
Invention
|
Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent. Histidine ... |
|
2001
|
Invention
|
Human kininogen d5 domain polypeptides and their use. Peptides form the human kininogen D5 domain... |
